Latest News
May 24, 2020
Cognitive behavioral therapy for insomnia was found to reduce severity of obstructive sleep apnea (OSA) by 15% in patients with comorbid insomnia and OSA, according to study findings.
May 24, 2020
Trastuzumab deruxtecan, an antibody–drug conjugate (ADC) marketed as Enhertu, has been granted Orphan Drug Designation (ODD) for the treatment of gastric cancer, including gastroesophageal junction cancer.
May 23, 2020
A majority of women younger than 45 years faced employment and insurance coverage difficulties following treatment for early stage breast cancer, with 35% fearing loss of health insurance coverage if they left their current job during treatment—despite wanting to continue working.
May 23, 2020
Ruxolitinib was found to be more cost-effective than the best available therapy (BAT) when the willingness-to-pay threshold for payers was at $150,000 and applied to patients with hydroxyurea resistant/intolerant polycythemia vera (PV) without splenomegaly, according to a new study.
May 23, 2020
Findings from the American Society for Radiation Oncology (ASTRO) highlight the growing financial strain at freestanding clinics, including those that say they will lose half their annual revenue.
May 23, 2020
Psoriatic arthritis and psoriasis both place a significant economic burden on patients, but a new analysis shows the burden on people with the former is significantly higher.
May 23, 2020
Samsung Bioepis announced positiive trial results for its ranibizumab biosimilar (SB11.
May 23, 2020
The bruton tyrosine kinase inhibitor zanubrutinib was shown to generate high response rates in a new study of patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma.
May 23, 2020
Jerry Bagel, MD, director of the Psoriasis Treatment Center of New Jersey, sheds light on the clinical utility of newer classes of biologic agents in the management of psoriasis and psoriatic arthritis.
May 23, 2020
The American Journal of Managed Care® discussed nationwide, state level takeaways of Sharecare's Flatten the Curve survey with Elizabeth Colyer, senior vice president of Community Well-Being Index at Sharecare.
